Na(+) entry via store-operated channels modulates Ca(2+) signaling in arterial myocytes

Am J Physiol Cell Physiol. 2000 Jan;278(1):C163-73. doi: 10.1152/ajpcell.2000.278.1.C163.

Abstract

In many nonexcitable cells, hormones and neurotransmitters activate Na(+) influx and mobilize Ca(2+) from intracellular stores. The stores are replenished by Ca(2+) influx via "store-operated" Ca(2+) channels (SOC). The main routes of Na(+) entry in these cells are unresolved, and no role for Na(+) in signaling has been recognized. We demonstrate that the SOC are a major Na(+) entry route in arterial myocytes. Unloading of the Ca(2+) stores with cyclopiazonic acid (a sarcoplasmic reticulum Ca(2+) pump inhibitor) and caffeine induces a large external Na(+)-dependent rise in the cytosolic Na(+) concentration. One component of this rise in cytosolic Na(+) concentration is likely due to Na(+)/Ca(2+) exchange; it depends on elevation of cytosolic Ca(2+) and is insensitive to 10 mM Mg(2+) and 10 microM La(3+). Another component is inhibited by Mg(2+) and La(3+), blockers of SOC; this component persists in cells preloaded with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid to buffer Ca(2+) transients and prevent Na(+)/Ca(2+) exchange-mediated Na(+) entry. This Na(+) entry apparently is mediated by SOC. The Na(+) entry influences Na(+) pump activity and Na(+)/Ca(2+) exchange and has unexpectedly large effects on cell-wide Ca(2+) signaling. The SOC pathway may be a general mechanism by which Na(+) participates in signaling in many types of cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Caffeine / pharmacology
  • Calcium / pharmacokinetics
  • Calcium Channels, L-Type / physiology
  • Calcium Signaling / physiology*
  • Cardiotonic Agents / pharmacology
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Cytosol / enzymology
  • Dinucleoside Phosphates / pharmacology
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Extracellular Space / metabolism
  • Female
  • Fluorescent Dyes
  • Fura-2
  • Indoles / pharmacology
  • Magnesium / pharmacology
  • Mesenteric Arteries / cytology
  • Mesenteric Arteries / enzymology
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / enzymology*
  • Ouabain / pharmacology
  • Phenylephrine / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sarcoplasmic Reticulum / enzymology
  • Sodium / pharmacokinetics*
  • Sodium-Calcium Exchanger / metabolism*
  • Sodium-Potassium-Exchanging ATPase / metabolism*
  • Vasoconstrictor Agents / pharmacology

Substances

  • Calcium Channels, L-Type
  • Cardiotonic Agents
  • Chelating Agents
  • Dinucleoside Phosphates
  • Enzyme Inhibitors
  • Fluorescent Dyes
  • Indoles
  • Phosphodiesterase Inhibitors
  • Sodium-Calcium Exchanger
  • Vasoconstrictor Agents
  • Angiotensin II
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Phenylephrine
  • cytidylyl adenosine
  • Caffeine
  • Egtazic Acid
  • Ouabain
  • Sodium
  • Sodium-Potassium-Exchanging ATPase
  • Magnesium
  • Calcium
  • Fura-2
  • cyclopiazonic acid